ARCHIVES

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

NCI Approved Clinical Trials

May 28, 2010

NIH Defends NCI Sponsored Travel

December 3, 2010

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007